CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Liability, Defined Benefit Plan
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Liability, Defined Benefit Plan of $1.00 million as of 2021-12-25, per its 10-K filed 2022-02-16.
Discontinued › Balance Sheet › Liabilities
us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent · last filed 2022-02-16
- 2021-12-25: Liability, Defined Benefit Plan $1.00M.
- 2020-12-26: Liability, Defined Benefit Plan $1.30M.
- 2019-12-28: Liability, Defined Benefit Plan $1.10M.
- 2018-12-29: Liability, Defined Benefit Plan $1.50M.
| Period end | Liability, Defined Benefit Plan | Liability, Defined Benefit Plan as first filed |
|---|---|---|
| 2021-12-25 | $1.00M 10-K · filed 2022-02-16 | |
| 2020-12-26 | $1.30M 10-K · filed 2022-02-16 | |
| 2019-12-28 | $1.10M 10-K · filed 2021-02-17 | |
| 2018-12-29 | $1.50M 10-K · filed 2020-02-11 | |
| 2017-12-30 | $1.40M 10-K · filed 2019-02-13 | |
| 2016-12-31 | $1.20M 10-K · filed 2018-02-13 | |
| 2015-12-26 | $900.00K 10-K · filed 2017-02-14 | |
| 2014-12-27 | $1.20M 10-K · filed 2016-02-12 | $1.18M 10-K · filed 2015-02-17 |
| 2013-12-28 | $1.10M 10-K · filed 2015-02-17 | $1.06M 10-K · filed 2014-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |